JD Health International Inc. (“JD Health”), with stock codes 6618 (HKD counter) and 86618 (RMB counter), plans to hold a Board meeting on Thursday, March 5, 2026. The meeting will address the annual results for the year ended December 31, 2025 and consider a final dividend distribution, if any.
A conference call will be held at 5:00 pm (Beijing/Hong Kong Time) on the same day to discuss these results. Participants are advised to dial in at least 10 minutes before the scheduled start time. The dial-in numbers are as follows: Mainland China 400 810 8228 (Mandarin)/400 810 8128 (English), Hong Kong +852 3005 1355 (Mandarin)/+852 3005 1313 (English), U.S. +1 6462543594, Singapore +65 68185374. The Mandarin Channel Participant Code is 187150, and the English Channel Participant Code is 611787. Further global dial-in information is accessible via the provided online link.
According to the announcement dated February 20, 2026, the Board comprises one executive Director, one non-executive Director, and five independent non-executive Directors. The executive Director is Mr. Dong Cao, the non-executive Director is Mr. Richard Qiangdong Liu, and the independent non-executive Directors are Ms. Ling Li, Dr. Jiyu Zhang, Mr. Xingyao Chen, Mr. Ying Wu, and Professor George Lau.